Novel Drug Shows 'Impressive' Efficacy in Polycythemia Vera

Norge Nyheter Nyheter

Novel Drug Shows 'Impressive' Efficacy in Polycythemia Vera
Norge Siste Nytt,Norge Overskrifter
  • 📰 Medscape
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 55%

Rusfertide, a first-in-class mimetic of hepcidin, shows high efficacy in the treatment of erythrocytosis polycythemia vera, with substantial improvements in hematocrit levels.

, with substantial improvements in hematocrit levels that can potentially eliminate the need for phlebotomies that are typically required – but usually ineffective.

PV, a relatively common clonal myeloproliferative neoplasm, is characterized by uncontrolled erythrocytosis, or excessive production of, increasing the risk for serious complications such as thromboembolic and cardiovascular events – the most common causes of morbidity and mortality in this blood cancer.

"This is somewhat of a paradigm shift," said Dr. Hoffman in the press briefing."We're trying to use a hormone made by the liver to control excessive red blood cell production from polycythemia vera." The second part was a withdrawal phase extending from weeks 29 to 41, in which patients were randomized in a blinded fashion to either continue on rusfertide or receive a placebo .

At the end of the second phase, 69.2% of patients receiving rusfertide were responders versus just 18.5% in the placebo group .

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

Medscape /  🏆 386. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

New Drug for Cannabis Use Disorder Shows Promise in Early Trials in HumansNew Drug for Cannabis Use Disorder Shows Promise in Early Trials in HumansA new pill could be the first to help the more than 14 million people in the U.S. who struggle to control their marijuana use
Les mer »

Can a Repurposed Parkinson's Drug Slow ALS Progression?Can a Repurposed Parkinson's Drug Slow ALS Progression?Ropinirole, a drug used for Parkinson's disease, shows promise in slowing the progression of amyotrophic lateral sclerosis, early research suggests. However, at least one expert believes the study has 'significant flaws.'
Les mer »

White House says Republicans are telling middle class to 'go to hell' on drug pricesWhite House says Republicans are telling middle class to 'go to hell' on drug pricesThe Biden administration is leaning into a new attack on congressional Republicans, suggesting that the GOP is colluding with 'Big Pharma' to keep medical prices elevated for middle-class and elderly Americans.
Les mer »

ReserveBlock RBX Network Introduces Novel Features, Offers On-Chain Escrow and In-Wallet RecoveryReserveBlock RBX Network Introduces Novel Features, Offers On-Chain Escrow and In-Wallet RecoveryNew-gen L1 blockchain ReserveBlock RBX Network makes its wallet experience more user-friendly; with new upgrade, non-custodial transfer value becomes safer than ever before
Les mer »

The Quiet Tenant: Blumhouse TV Nabs Rights to Psychological Thriller NovelThe Quiet Tenant: Blumhouse TV Nabs Rights to Psychological Thriller NovelBlumhouse Television has successfully acquired the rights to Clémence Michallon's debut novel titled The Quiet Tenant.
Les mer »



Render Time: 2025-03-04 21:57:10